The Centers for Disease Control and Prevention (CDC) awarded GT Molecular, Inc., doing business as GT Molecular LLC, a $1,665,445.00 firm-fixed-price contract to develop, optimize, and validate a portfolio of molecular testing assays for the National Wastewater Surveillance System (NWSS). This 5-year contract, with a 12-month base period and four 12-month option periods, is set aside for small businesses. GT Molecular, a minority-owned small disadvantaged business, will provide digital PCR-based assay services to support the CDC's efforts in monitoring multiple pathogens, antimicrobial resistance, and vector targets in wastewater. This award builds upon GT Molecular's previous contract work with the CDC and other federal agencies in the field of advanced molecular diagnostics and public health surveillance technologies.
Generated 12/11/24, 9:08 AM